Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma: A pilot study

CONCLUSIONS: Induction nab-paclitaxel plus cisplatin, nimotuzumab combined with IMRT, followed by S-1 adjuvant chemotherapy, yielded an excellent survival benefit with tolerable toxicities in patients with stage N3 NPC. Distant metastasis was the main cause of treatment failure.PMID:35381746 | DOI:10.4103/jcrt.jcrt_2145_21

Source: Cancer Control - April 6, 2022 Category: Cancer & Oncology Authors: Liya Zhou Jie Lin Jiawei Chen Shuai Zhang Source Type: research